# Pyruvate-Anaplerosis-is-a-Targetable-Vulnerability-in-Persistent-Leukaemic-Stem-Cells
This repository contains scripts pertaining to microarray, RNA-seq and survival analyses displayed in the paper "Pyruvate Anaplerosis is a Targetable Vulnerability in Persistent Leukaemic Stem Cells "

Kevin M. Rattigan<sup>1Ɨ</sup>, Zuzana Brabcova<sup>1Ɨǂ</sup>, Daniele Sarnello<sup>1</sup>, Martha M. Zarou<sup>1</sup>, Kiron Roy<sup>1</sup>, Ryan Kwan<sup>2</sup>, Lucie de Beauchamp<sup>1</sup>, Amy Dawson<sup>1</sup>, Angela Ianniciello<sup>1</sup>, Ahmed Khalaf<sup>1</sup>, Eric R. Kalkman<sup>1</sup>, Mary T. Scott<sup>1</sup>, Karen Dunn<sup>3</sup>, David Sumpton<sup>2</sup>, Alison M. Michie<sup>3</sup>, Mhairi Copland<sup>3</sup>, Saverio Tardito<sup>1,2</sup>, Eyal Gottlieb<sup>4</sup>, G. Vignir Helgason<sup>1</sup>

1. Wolfson Wohl Cancer Research Centre; Institute of Cancer Sciences, University of Glasgow, Glasgow, G61 1QH, UK.
2. Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK.
3.Paul O’Gorman Leukaemia Research Centre; Institute of Cancer Sciences, University of Glasgow, Glasgow, G12 0ZD, UK.
4. The Ruth and Bruce Rappaport Faculty of Medicine; Technion-Israel Institute of Technology, Haifa, Israel.
